CHEMICAL STRUCTURE--HYPOTHALAMIC NA+/K+ ATPASE INHIBITOR
化学结构--下丘脑NA /K ATP酶抑制剂
基本信息
- 批准号:2029119
- 负责人:
- 金额:$ 44.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-04-01 至 2000-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: Hypothalamic inhibitory factor, HIF, is felt to be a mammalian
analog of the digitalis glycosides with biologic and biochemical properties
consistent with physiologic regulation of the mammalian sodium pump in
cardiovascular, renal and nervous system tissues in vivo. Disregulation of
the inhibitor-Na,K-ATPase system has been linked to the pathogenesis of
human essential hypertension. Structural analysis of pure HIF showed it to
be an isomer, differing in the steroid moiety, of the plant glycoside,
ouabain. Recently, an ouabain-like compound (OLC) isolated from human
plasma and felt to be indistinguishable from plant ouabain has been
restudied and found to be different from ouabain but identical to HIF,
further supporting the notion that a unique molecule may specifically
regulate the human Na,K-ATPase. The simplest explanation consistent with
our spectroscopic data was that HIF differed from ouabain as a position
isomer rhamnoside. We synthesized eight of these peracylated analogs and
obtained their CD spectra. None of them showed weak CD curves (nearly zero)
which is the signature of pentanaphthoyl HIF and OLC, nor did calculated CD
spectra of remaining position isomers, with the possible exception of the C5
rhamnoside. With the likelihood of a more complex difference in the steroid
moiety, an affinity purification method was developed using a monoclonal
anti-digoxin antibody which resulted in high yields of pure HIF, making
complete structural assignment of the endogenous Na,K-ATPase inhibitor
achievable. Development of monoclonal antibodies to characterize HIF and
create a diagnostic assay is newly proposed.
描述:下丘脑抑制因子(Hypothalamic inhibitory factor, HIF)被认为是一种哺乳动物
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Garner Tripp Haupert其他文献
Garner Tripp Haupert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Garner Tripp Haupert', 18)}}的其他基金
CHEMICAL STRUCTURE OF HYPOTHALAMIC NA/K ATPASE INHIBITOR
下丘脑 NA/K ATP 酶抑制剂的化学结构
- 批准号:
2229582 - 财政年份:1994
- 资助金额:
$ 44.65万 - 项目类别:
CHEMICAL STRUCTURE--HYPOTHALAMIC NA+/K+ ATPASE INHIBITOR
化学结构--下丘脑NA /K ATP酶抑制剂
- 批准号:
6043823 - 财政年份:1994
- 资助金额:
$ 44.65万 - 项目类别:
CHEMICAL STRUCTURE OF HYPOTHALAMIC NA/K ATPASE INHIBITOR
下丘脑 NA/K ATP 酶抑制剂的化学结构
- 批准号:
2229583 - 财政年份:1994
- 资助金额:
$ 44.65万 - 项目类别:
CHEMICAL STRUCTURE--HYPOTHALAMIC NA+/K+ ATPASE INHIBITOR
化学结构--下丘脑NA /K ATP酶抑制剂
- 批准号:
2750414 - 财政年份:1994
- 资助金额:
$ 44.65万 - 项目类别:
CHEMICAL STRUCTURE OF HYPOTHALAMIC NA/K ATPASE INHIBITOR
下丘脑 NA/K ATP 酶抑制剂的化学结构
- 批准号:
2229581 - 财政年份:1994
- 资助金额:
$ 44.65万 - 项目类别:
CHARACTERIZATION OF HYPOTHALAMIC NA+ TRANSPORT INHIBITOR
下丘脑 NA 转运抑制剂的特性
- 批准号:
3345504 - 财政年份:1984
- 资助金额:
$ 44.65万 - 项目类别:
CHARACTERIZATION OF HYPOTHALAMIC NA+ TRANSPORT INHIBITOR
下丘脑 NA 转运抑制剂的特性
- 批准号:
3345505 - 财政年份:1984
- 资助金额:
$ 44.65万 - 项目类别:
相似海外基金
MRI: Acquisition of an X-ray Diffractometer for Research and Training in Chemical Structure-Function Studies
MRI:购买 X 射线衍射仪用于化学结构-功能研究的研究和培训
- 批准号:
1726630 - 财政年份:2017
- 资助金额:
$ 44.65万 - 项目类别:
Standard Grant














{{item.name}}会员




